Vectura Group (VEC) Health Care Sector

  • Latest quote

    72.50p (mid)

  • Current Change (%)

    0.00%

  • Price

    Bid: 72.30p

    Offer: 72.45p

  • Today

    High: 73.16p

    Low: 70.60p

  • This year

    High: 104.60p

    Low: 68.50p

  • Information

    Volume: 433,559

    Market Cap: £482.13M



Vectura Group Overview

Vectura develops inhaled therapies principally for the treatment of respiratory diseases.

Vectura Group RNS Feed

Title Release date
Holding(s) in Company 15:09 - April 18, 2019
Annual Report and Accounts 2018 and AGM 2019 12:41 - April 16, 2019
Total Voting Rights 10:36 - April 1, 2019
BLOCK LISTING RETURN 10:36 - April 1, 2019
Kevin Matthews appointed to Board of Directors 10:00 - April 1, 2019
Vectura 2018 Preliminary Results 07:00 - March 26, 2019
Total Voting Rights and Capital 09:09 - March 1, 2019
Total Voting Rights and Capital 10:14 - February 1, 2019
Holdings in Company 16:18 - January 7, 2019
Total Voting Rights and Capital 12:29 - January 2, 2019
Update on UK GSK patent litigation 12:34 - December 13, 2018
Block Listing Return 09:44 - December 3, 2018
Total Voting Rights and Capital 09:40 - December 3, 2018
Results for VR475 in severe uncontrolled asthma 07:00 - November 26, 2018
flutiform receives positive opinion in Europe 10:00 - November 9, 2018

NOTE: This is based on 65 open tips for this company


Total Number of Share tips :

79

View all Vectura Group Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today